Fortrea Announces Date for Third Quarter 2024 Financial Results and Conference Call

FTRE 10.14.2024

SERA-AI Powered Highlights
Date of Upcoming Event:2024-11-08
Name of Upcoming Event:Earnings Call
Full Press ReleaseSEC FilingsOur FTRE Tweets

About Gravity Analytica

Recent News

  • 01.23.2025 - Highlighting Fortrea’s commitment to advancing rare disease clinical research
  • 01.20.2025 - Rapid diagnostic advantages in clinical research
  • 01.20.2025 - Leveraging Technology for Vaccine Trial Surveillance

Recent Filings

  • 01.14.2025 - 4 Statement of changes in beneficial ownership of securities
  • 01.13.2025 - 144 Report of proposed sale of securities

DURHAM, N.C., Oct. 14, 2024 (GLOBE NEWSWIRE) --Fortrea(Nasdaq: FTRE) (the “Company”), a leading global contract research organization (“CRO”), today announced that it will release its third quarter 2024 financial results before the market opens on Friday, November 8, 2024. Fortrea will host a conference call at 8:00 am ET that day to review its financial results and conduct a question-and-answer session.

To participate in the earnings call, participants should register online at theFortrea Investor Relations website. To avoid potential delays, please join at least 10 minutes prior to the start of the call. The conference call can also be accessed through the followingearnings webcast link.

A replay of the live conference call will be available shortly after the conclusion of the event and accessible on the events and presentations section of the Fortrea Investor Relations website.

About FortreaFortrea (Nasdaq: FTRE) is a leading global provider of clinical development solutions to the life sciences industry. We partner with emerging and large biopharmaceutical, biotechnology, medical device and diagnostic companies to drive healthcare innovation that accelerates life changing therapies to patients. Fortrea provides phase I-IV clinical trial management, clinical pharmacology and consulting services. Fortrea’s solutions leverage three decades of experience spanning more than 20 therapeutic areas, a passion for scientific rigor, exceptional insights and a strong investigator site network. Our talented and diverse team working in about 100 countries is scaled to deliver focused and agile solutions to customers globally. Learn more about how Fortrea is becoming a transformative force from pipeline to patient atFortrea.comand follow us onLinkedInandX(formerly Twitter).

Fortrea Contacts:Hima Inguva (Investors) – 877-495-0816,hima.inguva@fortrea.comSue Zaranek (Media) – 919-943-5422,media@fortrea.comKate Dillon (Media) – 646-818-9115,kdillon@prosek.com

Please be aware that the following content has been generated by an AI system and may contain errors, inconsistencies, or outdated information. It is provided as-is without any warranties or guarantees of accuracy. We strongly recommend using this content as a starting point for further research and consultation with relevant experts or authorities. We disclaim any liability for damages or losses resulting from the use or reliance on this content.Please note that this is a beta version of the Gravity Analytica LLC’s AI Service which isstill undergoing final testing before its official release. Theplatform, its software and all content found on it are provided on an“as is” and “as available” basis. Gravity Analytica LLC does not give any warranties,whether express or implied, as to the suitability or usability of thisservice, webpage, or its software or any of its content.Should you encounter any bugs, glitches, lack of functionality orother problems on the website, please let us know immediately so wecan rectify these accordingly. Your help in this regard is greatlyappreciated! You can write to us at this addressteam@gravityanalytica.com